Drugs & medicalClass II

Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalls TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single…

Incorrect Product Formulation: product did not contain insulin as listed in the label.

Read the official notice →
Date
2026-05-13
Country
United States
Brand
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
Product
TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection,…
Classification
Class II
Units
CA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalls

  1. 2025-07-23
  2. US
    Drugs & medicalClass II

    Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalls PERIPHERAL PARENTERAL NUTRITION, Compounded Sterile Preparation, Refrigerated Injection, Rx Only,…

    Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.

    FDA · DrugCentral Admixture Pharmacy Services, Inc (CAPS) Los AngelesCAOfficial notice →
All 2 Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalls →

Other drugs & medical recalls in the United States

  1. 2026-05-13
  2. US
    Drugs & medicalClass I

    Cook Incorporated recalls Centimeter Sizing Catheter RPN N5.0-35-100-P-10S-PIG-CSC-20 GPN G11916 Catheters for use in angiographic procedures are available in a…

    Marker bands may be at an increased risk of cracking/breakage. Potential adverse events that may result include increased procedural time, harms associated with device fragmentation/separation, and vessel injury. In a…

    FDA · DeviceCook IncorporatedUS distribution nationwide. OUS distribution to Brunei, Brazil, Canda, China,…Official notice →
  3. US
    Drugs & medicalClass I

    Intuitive Surgical, Inc. recalls Intuitive 8 mm SureForm 30 Gray Reloads Reference Numbers: 48230M-05 and 48230M-06

    Reloads for curved-tipped stapler may potentially produce an incomplete staple line.

    FDA · DeviceIntuitive Surgical, Inc.US: Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware…Official notice →
  4. US
  5. US
    Drugs & medicalClass II

    Acella Pharmaceuticals, LLC recalls NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC,…

    Chemical contamination; presence of lead and lithium above specification

    FDA · DrugAcella Pharmaceuticals, LLCNationwideOfficial notice →
  6. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-count bottle, Mfr. by Towa Pharmaceutical Eurpoe S.L., Martorelles,…

    CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

    FDA · DrugBreckenridge Pharmaceutical, Inc.Nationwide in the USAOfficial notice →
  7. US
    Drugs & medicalClass II

    JB Chemicals and Pharmaceuticals Ltd recalls Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A…

    Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

    FDA · DrugJB Chemicals and Pharmaceuticals LtdNationwide in the USAOfficial notice →
See all drugs & medical recalls →